iX Biopharma Ltd. (SG:42C) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
iX Biopharma Ltd has announced a reduction in net proceeds from its Rights cum Warrants Issue to $1.55 million after a significant shareholder, Anson Properties, was unable to fulfill its subscription commitment due to timing of funds. Anson Properties still intends to invest in the company within the next four to six weeks. The company reassures that this event will not materially impact operations or finances and will keep the market updated through SGXNET.
For further insights into SG:42C stock, check out TipRanks’ Stock Analysis page.
